NICE have published a new guide to help commissioners, clinicians and managers who commission services for people with common mental health disorders. Here’s the blurb from the NICE press release: Approaching the commissioning of mental health services as part of an integrated care pathway and illustrated with service models, the NICE guide for commissioners identifies [read the full story…]
The manufacturer of agomelatine (Servier) has informed NICE that it would not be making an evidence submission for the appraisal of agomelatine for the treatment of major depressive episodes. Servier drew attention to the fact that NICE guidelines for England and Wales recommend generic selective serotonin reuptake inhibitors (SSRIs) as first-line treatment followed by a [read the full story…]
